The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients
Abstract Background Tranexamic acid (TXA) is an antifibrinolytic drug that blocks lysine-binding sites on the profibrinolytic enzyme plasminogen. Aortic diseases with chronic consumption coagulopathy may lead to disseminated intravascular coagulation (DIC) and cause fatal bleeding. Although the use...
Main Authors: | Naruko Suzuki, Nobuaki Suzuki, Yuka Kawaguchi, Shuichi Okamoto, Takeshi Kanematsu, Akira Katsumi, Atsuo Suzuki, Shogo Tamura, Tetsuhito Kojima, Hitoshi Kiyoi, Tadashi Matsushita |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-022-00429-4 |
Similar Items
-
Oral tranexamic acid combined with low molecular weight heparin only during dialysis sessions successfully controlled chronic disseminated intravascular coagulation associated with aortic aneurysm and aortic dissection in a dialysis patient: a case report with literature review
by: Eriko Eguchi
Published: (2019-08-01) -
Aneurysm-related disseminated intravascular coagulation successfully treated by endovascular repair
by: Miguel Lemos Gomes, et al.
Published: (2019-12-01) -
Placenta Accreta Spectrum Prophylactic Therapy for Hyperfibrinolysis with Tranexamic Acid
by: Tiyasha Hosne Ayub, et al.
Published: (2023-12-01) -
Tubercular aortoiliac aneurysm with challenging management
by: Mansi Shah, et al.
Published: (2023-01-01) -
Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis
by: Atsuo Suzuki, et al.
Published: (2022-01-01)